Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer

[1]  M. Gross,et al.  Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer. , 2010, Clinical chemistry.

[2]  Mehmet Toner,et al.  Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer , 2010, Science Translational Medicine.

[3]  Emmanuel R. Yera,et al.  Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. , 2009, Cancer letters.

[4]  Jun Luo,et al.  Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.

[5]  T. Ragg,et al.  Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Dearnaley,et al.  Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. , 2009, Cancer research.

[7]  Oscar Lin,et al.  Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer , 2009, Clinical Cancer Research.

[8]  Mieke Schutte,et al.  Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells , 2009, Journal of the National Cancer Institute.

[9]  John A. Foekens,et al.  Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR , 2009, Breast Cancer Research and Treatment.

[10]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[11]  Jianfeng Xu,et al.  Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer. , 2008, Neoplasia.

[12]  B. Trask,et al.  Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients. , 2008, Cancer research.

[13]  Ruud H. Brakenhoff,et al.  Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.

[14]  R. Reinhardt,et al.  High-resolution array comparative genomic hybridization of single micrometastatic tumor cells , 2008, Nucleic acids research.

[15]  M. Speicher,et al.  Single-cell isolation from cell suspensions and whole genome amplification from single cells to provide templates for CGH analysis , 2007, Nature Protocols.

[16]  Glenn Heller,et al.  Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.

[17]  David D. Smith,et al.  Challenges in array comparative genomic hybridization for the analysis of cancer samples , 2007, Genetics in Medicine.

[18]  Jin Woo Kim,et al.  DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies , 2007, The Prostate.

[19]  Michael R. Speicher,et al.  High resolution array-CGH analysis of single cells , 2006, Nucleic acids research.

[20]  J. Mendelsohn,et al.  Circulating tumor cells in breast cancer: Advanced tools for “tailored” therapy? , 2006, Proceedings of the National Academy of Sciences.

[21]  D. Pinkel,et al.  A large field CCD system for quantitative imaging of microarrays , 2006, Nucleic acids research.

[22]  J. Nesland,et al.  Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer , 2006, International journal of cancer.

[23]  H. Scher,et al.  Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  K. Pienta,et al.  Global gene expression profiling of circulating tumor cells. , 2005, Cancer research.

[25]  Alison Stopeck,et al.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Richard Segraves,et al.  Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors. , 2005, The Journal of molecular diagnostics : JMD.

[27]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[28]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[29]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[30]  Rameen Beroukhim,et al.  Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. , 2004, Nucleic acids research.

[31]  Ajay N. Jain,et al.  Fully automatic quantification of microarray image data. , 2002, Genome research.

[32]  Ajay N. Jain,et al.  Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.

[33]  S. Devries,et al.  Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. , 2000, Journal of the National Cancer Institute.

[34]  M. Speicher,et al.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T C Gasser,et al.  Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. , 1999, Cancer research.

[36]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[37]  A. Weiss,et al.  Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Jorma Isola,et al.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.